These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 26060511)

  • 1. The impact of diabetes on cognitive decline: potential vascular, metabolic, and psychosocial risk factors.
    Feinkohl I; Price JF; Strachan MW; Frier BM
    Alzheimers Res Ther; 2015; 7(1):46. PubMed ID: 26060511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetic retinopathy and cognitive decline in older people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study.
    Ding J; Strachan MW; Reynolds RM; Frier BM; Deary IJ; Fowkes FG; Lee AJ; McKnight J; Halpin P; Swa K; Price JF;
    Diabetes; 2010 Nov; 59(11):2883-9. PubMed ID: 20798334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive impairment and diabetes.
    Dash SK
    Recent Pat Endocr Metab Immune Drug Discov; 2013 May; 7(2):155-65. PubMed ID: 23489242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe hypoglycemia and cognitive decline in older people with type 2 diabetes: the Edinburgh type 2 diabetes study.
    Feinkohl I; Aung PP; Keller M; Robertson CM; Morling JR; McLachlan S; Deary IJ; Frier BM; Strachan MW; Price JF;
    Diabetes Care; 2014 Feb; 37(2):507-15. PubMed ID: 24103900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive impairment in diabetic patients: Can diabetic control prevent cognitive decline?
    Kawamura T; Umemura T; Hotta N
    J Diabetes Investig; 2012 Oct; 3(5):413-23. PubMed ID: 24843599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between pre-diabetes and microvascular and macrovascular disease in newly diagnosed type 2 diabetes.
    Palladino R; Tabak AG; Khunti K; Valabhji J; Majeed A; Millett C; Vamos EP
    BMJ Open Diabetes Res Care; 2020 Apr; 8(1):. PubMed ID: 32332069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers for cognitive decline in patients with diabetes mellitus: evidence from clinical studies.
    Zhao X; Han Q; Lv Y; Sun L; Gang X; Wang G
    Oncotarget; 2018 Jan; 9(7):7710-7726. PubMed ID: 29484146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association.
    Gorelick PB; Scuteri A; Black SE; Decarli C; Greenberg SM; Iadecola C; Launer LJ; Laurent S; Lopez OL; Nyenhuis D; Petersen RC; Schneider JA; Tzourio C; Arnett DK; Bennett DA; Chui HC; Higashida RT; Lindquist R; Nilsson PM; Roman GC; Sellke FW; Seshadri S;
    Stroke; 2011 Sep; 42(9):2672-713. PubMed ID: 21778438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations between recent severe hypoglycemia, retinal vessel diameters, and cognition in adults with type 1 diabetes.
    Ryan CM; Klein BEK; Lee KE; Cruickshanks KJ; Klein R
    J Diabetes Complications; 2016; 30(8):1513-1518. PubMed ID: 27601058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathophysiological Mechanisms Linking Type 2 Diabetes and Dementia: Review of Evidence from Clinical, Translational and Epidemiological Research.
    Bello-Chavolla OY; Antonio-Villa NE; Vargas-Vázquez A; Ávila-Funes JA; Aguilar-Salinas CA
    Curr Diabetes Rev; 2019; 15(6):456-470. PubMed ID: 30648514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioural interventions for type 2 diabetes: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(21):1-45. PubMed ID: 23074526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between impaired glucose tolerance, type 2 diabetes, and cognitive function.
    Awad N; Gagnon M; Messier C
    J Clin Exp Neuropsychol; 2004 Nov; 26(8):1044-80. PubMed ID: 15590460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of age at type 2 diabetes mellitus diagnosis on mortality and vascular complications: systematic review and meta-analyses.
    Nanayakkara N; Curtis AJ; Heritier S; Gadowski AM; Pavkov ME; Kenealy T; Owens DR; Thomas RL; Song S; Wong J; Chan JC; Luk AO; Penno G; Ji L; Mohan V; Amutha A; Romero-Aroca P; Gasevic D; Magliano DJ; Teede HJ; Chalmers J; Zoungas S
    Diabetologia; 2021 Feb; 64(2):275-287. PubMed ID: 33313987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurocognitive impairment in type 2 diabetes mellitus.
    Karvani M; Simos P; Stavrakaki S; Kapoukranidou D
    Hormones (Athens); 2019 Dec; 18(4):523-534. PubMed ID: 31522366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and subclinical macrovascular disease as predictors of cognitive decline in older patients with type 2 diabetes: the Edinburgh Type 2 Diabetes Study.
    Feinkohl I; Keller M; Robertson CM; Morling JR; Williamson RM; Nee LD; McLachlan S; Sattar N; Welsh P; Reynolds RM; Russ TC; Deary IJ; Strachan MW; Price JF;
    Diabetes Care; 2013 Sep; 36(9):2779-86. PubMed ID: 23579182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic memory: Evolving concepts.
    Misra A; Bloomgarden Z
    J Diabetes; 2018 Mar; 10(3):186-187. PubMed ID: 29091343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinically significant cognitive impairment in older adults with type 1 diabetes.
    Chaytor NS; Barbosa-Leiker C; Ryan CM; Germine LT; Hirsch IB; Weinstock RS
    J Diabetes Complications; 2019 Jan; 33(1):91-97. PubMed ID: 29728302
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.